Primary PCI equally effective in cancer patients with STEMI and those without cancer: Study

Delhi: Primary PCI is underused in cancer patients with active STEMI, despite it being associated with lower MACCE and in-hospital mortality just like in patients without cancer, reveals a recent study. The findings of the study are published in the European Heart Journal.

Primary percutaneous coronary intervention (pPCI) is thestandard of care for patients presenting with ST-elevation myocardial infarction (STEMI). However, the data on its use and effectiveness in cancer patients with active STEMI is limited. To fill this knowledge gap, Mamas A Mamas, Population Health Research Institute, Hamilton, Canada, and colleagues retrospectively analysed all STEMI hospitalizations between 2004 and 2015 from the National Inpatient Sample. They performed propensity score matching for estimating the average treatment effect of pPCI in each cancer on in-hospital adverse events, including major adverse cardiovascular and cerebrovascular events (MACCE) and its individual components.and compared treatment effect between cancer and non-cancer patients.